Prospective Phase II trial of drug-eluting bead chemoembolization for liver transplant candidates with hepatocellular carcinoma and marginal hepatic reserve.

Fidelman, Nicholas; Johanson, Curt; Kohi, Maureen P; Kolli, K Pallav; Kohlbrenner, Ryan M; Lehrman, Evan D; Taylor, Andrew G; Kelley, R Kate; Yao, Francis Y; Roberts, John P; Kerlan, Robert K

Fidelman, Nicholas; Johanson, Curt; Kohi, Maureen P; Kolli, K Pallav; Kohlbrenner, Ryan M; Lehrman, Evan D; Taylor, Andrew G; Kelley, R Kate; Yao, Francis Y; Roberts, John P; Kerlan, Robert K.

Afiliação

Fidelman N; Department of Radiology and Biomedical Imaging.
Johanson C; Department of Radiology and Biomedical Imaging.
Kohi MP; Department of Radiology and Biomedical Imaging.
Kolli KP; Department of Radiology and Biomedical Imaging.
Kohlbrenner RM; Department of Radiology and Biomedical Imaging.
Lehrman ED; Department of Radiology and Biomedical Imaging.
Taylor AG; Department of Radiology and Biomedical Imaging.
Kelley RK; Department of Medicine - Division of Gastrointestinal Oncology.
Yao FY; Department of Medicine - Division of Hepatology.
Roberts JP; Department of Surgery - Division of Transplant Surgery, University of California San Francisco, San Francisco, CA, USA.
Kerlan RK; Department of Radiology and Biomedical Imaging.

J Hepatocell Carcinoma ; 6: 93-103, 2019.

Article em En | MEDLINE | ID: mdl-31355158

Palavras-chave

chemoembolization; hepatocellular carcinoma; liver transplantation

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google

Texto completo: 1 Coleções: 01-internacional Contexto em Saúde: 6_ODS3_enfermedades_notrasmisibles Base de dados: MEDLINE Tipo de estudo: Risk_factors_studies Idioma: En Revista: J Hepatocell Carcinoma Ano de publicação: 2019 Tipo de documento: Article

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google